SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

8609	Companies
141539	Keywords
77444	Articles
75638	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 03/24/2025 at 07:30, 17 days 15 hours ago

Press Release: Availability of the Q1 2025 Aide mémoire
Sanofi announced the availability of the Q1 2025 Aide mémoire on its website to assist in financial modeling, including non-comparable items and first quarter reminders

Sanofi Financial Modeling Aide Mémoire Q1 2025 Exclusivity Losses
PRESS RELEASE

published on 03/10/2025 at 21:09, 1 month ago

Sanofi: Disclosure of trading in own shares
BRIEF

published on 03/08/2025 at 19:05, 1 month 2 days ago

Sanofi-Aventis Reports Positive Data for Dupixent in Bullous Pemphigoid

Clinical Study Dupixent Type 2 Inflammation Bullous Pemphigoid Regulatory Review
PRESS RELEASE

published on 03/08/2025 at 19:00, 1 month 2 days ago

Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
Positive pivotal data for Dupixent in bullous pemphigoid presented at AAD, showing significant disease remission and reduction in severity, itch, and medication use. Regulatory submissions under review in US and EU

Dupixent Type 2 Inflammation Bullous Pemphigoid AAD Sustained Remission
BRIEF

published on 02/25/2025 at 07:05, 1 month 13 days ago

Sarclisa Gains Approval in Japan for Multiple Myeloma Treatment

Multiple Myeloma Sarclisa Approval Sanofi Oncology Japan Healthcare IMROZ Study
PRESS RELEASE

published on 02/25/2025 at 07:00, 1 month 13 days ago

Press Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma
Sarclisa approved in Japan for newly diagnosed multiple myeloma patients, offering new treatment options based on positive IMROZ phase 3 study results

Oncology Japan Multiple Myeloma Sarclisa IMROZ Study
PRESS RELEASE

published on 02/24/2025 at 21:27, 1 month 14 days ago

Sanofi: Disclosure of trading in own shares
BRIEF

published on 02/22/2025 at 08:35, 1 month 16 days ago

Sanofi-Teva: Duvakitug Promises for Inflammatory Bowel Diseases

Ulcerative Colitis Crohn's Disease Duvakitug RELIEVE UCCD Sanofi-Teva
PRESS RELEASE

published on 02/22/2025 at 08:30, 1 month 16 days ago

Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease
Sanofi and Teva Pharmaceuticals present new detailed data from the RELIEVE UCCD study on duvakitug's efficacy in ulcerative colitis and Crohn's disease at ECCO 2025, demonstrating potential for phase 3 program in H2 2025

Ulcerative Colitis Sanofi Teva Pharmaceuticals Crohn's Disease RELIEVE UCCD Study
BRIEF

published on 02/19/2025 at 07:35, 1 month 19 days ago

Sanofi and CD&R Finalize Opella Share Purchase Agreement

Share Purchase Regulatory Approvals Sanofi CD&R Opella

Accesswire

Published on 04/10/2025 at 22:15, 16 minutes ago

Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program
Published on 04/10/2025 at 22:15, 16 minutes ago

SWK Holdings Announces Closing of Royalty Sale and $4.00 Per Share Special Dividend
Published on 04/10/2025 at 19:00, 3 hours 31 minutes ago

D. Boral Capital Acted as Sole Bookrunner to FatPipe, Inc. (Nasdaq: FATN) in Connection with its $4.0 Million Initial Public Offering
Published on 04/10/2025 at 15:15, 7 hours 16 minutes ago

ReelTime’s Reel Intelligence "RI" Outperforms AI While Requiring a Fraction of The Resources
Published on 04/10/2025 at 15:00, 7 hours 31 minutes ago

Route1 Signs Significant New Orders with Major Cities in the Southwestern United States and Announces Key Corporate Updates Including Its Acquisition Growth Strategy

View all ACCESSWIRE

EQS Group

Published on 04/10/2025 at 20:47, 1 hour 44 minutes ago

EQS-Adhoc: Hinkel & Cie. GmbH: first creditors´meeting of the bond DE000A2AAPX4
Published on 04/10/2025 at 20:44, 1 hour 47 minutes ago

EQS-Adhoc: artnet AG: artnet is in talks with two investors regarding a potential takeover offer
Published on 04/10/2025 at 19:00, 3 hours 31 minutes ago

Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Published on 04/10/2025 at 18:57, 3 hours 34 minutes ago

EQS-Adhoc: HAMBORNER REIT AG: Adjustment of dividend strategy
Published on 04/10/2025 at 18:28, 4 hours 3 minutes ago

Travis Perkins: Director/PDMR Shareholding

Les Echos

Published on 04/10/2025 at 17:45, 4 hours 46 minutes ago

EURAZEO INVESTS IN EKOSCAN INTEGRITY, A LEADING GLOBAL PROVIDER OF ADVANCED NON-DESTRUCTIVE TESTING SOLUTIONS FOR CRITICAL INDUSTRIAL APPLICATIONS AND INFRASTRUCTURE
Published on 04/10/2025 at 17:27, 5 hours 4 minutes ago

2024 URD - Universal Registration Document
Published on 04/09/2025 at 18:59, 1 day 3 hours ago

Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:57, 1 day 3 hours ago

Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 17:45, 1 day 4 hours ago

COGELEC : 2024 full-year results and Q1 2025 revenue.

View all LES ECHOS COMFI WIRE